Amino acid profile in blood: when this test actually tells you something

You are sitting in front of a price list. Between the vitamin D value and ferritin there is one line that sounds different from the rest: amino acid profile, thirty-two parameters. And you think what many people think at this point. If amino acids are the building blocks of everything, then surely this test must tell you more than any other.

I understand that hope very well. It is logical. It just took a wrong turn at one point.

Because an amino acid profile does not measure your building blocks. It measures the small share of them that happens to be travelling between two building sites. And the body regulates that share so tightly that in many situations it looks surprisingly normal, even when something is off in the background.

At the same time there are situations in which exactly this test can save children's lives, and has done so for decades. Both are true. The interesting part lies in between, and that is what this article is about.

Blood is a river, not a storage room

Picture a large building site. Tonnes of material are lying on the ground. And lorries are constantly rolling in and out of the entrance, bringing material and taking it away.

If you wanted to know how much material is lying on that site, it would be a poor idea to stand at the entrance and count the lorries. But that is exactly what a plasma amino acid profile does.

The numbers behind this are striking. An adult carries roughly ten to twelve kilograms of body protein. The pool of free amino acids that a blood test can touch sits in the range of a few hundred grams, and the share of that in blood plasma is smaller again by a good margin. Every day several hundred grams of body protein are broken down and rebuilt. So the small pool is being flushed through constantly.

That is exactly why the body keeps it stable. If an amino acid drops in blood, muscle can release it. If it rises, the liver can break it down or convert it into other substances. This is homeostasis in its purest form: a feedback loop that protects your blood values rather more than your reserves.

And now you know why I always start by asking which question this test is supposed to answer.

Where the amino acid profile is undisputed medicine

Before I get critical, the other side belongs on the table. Because there are areas in which this test is not up for debate. There it has been standard for decades, and it is well supported.

The first is newborn screening and the work-up of inborn metabolic disorders. A few drops of blood from the heel, a mass spectrometer, and a child with phenylketonuria can be identified in the first days of life instead of developing a lasting developmental disorder over the first years.

The second area is the work-up of rare metabolic diseases beyond screening. Here it is often not single values but ratios between amino acids that make a diagnosis possible.

The third established area is the liver. In advanced liver disease the ratio between branched-chain and aromatic amino acids shifts, because the liver can no longer break down the aromatic ones at the same pace and muscle uses up the branched-chain ones for ammonia detoxification. This ratio has carried the name Fischer ratio since the nineteen seventies.

A Danish investigation in six healthy people, thirteen people with liver cirrhosis and six people with alcoholic hepatitis found exactly this picture: the Fischer ratio averaged 2.73 in the healthy participants, 1.65 in cirrhosis and 1.17 in alcoholic hepatitis. It was also negatively linked to the severity of the disease. This work measured whole blood, not plasma, which limits the direct comparison with plasma values.

The fourth area is nutritional medicine in severe illness: long-term artificial nutrition, short bowel syndrome, pronounced malnutrition, intensive care. There a profile is part of the steering, not part of a curiosity.

And now you know why I do not reject this test. I only want us to know beforehand what we are looking for.

Pre-analytics: half the value is decided before the needle

This is the least romantic section of the article. And the most important one.

I have seen profiles that looked abnormal, and when I asked further it turned out that the draw was in the afternoon, after a protein shake, and the tube stood on the counter for two hours before it was centrifuged. Results like that tell you nothing about the person. They tell you something about the procedure.

On top of that come factors nobody in the laboratory can see, because they sit in your everyday life.

And now you know why I am so pedantic about this topic.

The six axes a profile can tell you about

When a profile has been drawn well and there is a clear question behind it, there are six places I look at more closely. Not because the answer is there, but because that is where questions arise that lead somewhere.

Methionine, homocysteine and methylation

Methionine is the entrance door into one of the body's most important cycles. From methionine comes S-adenosylmethionine, the universal methyl group donor. It supplies the production of messenger substances, the packaging of DNA and the building of cell membranes. After the methyl group has been handed over, homocysteine is left.

Homocysteine then has two routes. One leads back to methionine and needs folate and vitamin B12 for it. The other leads onward through what is called transsulfuration to cysteine, the building block for glutathione, and needs vitamin B6 for it. A detailed review describes that around half of the cysteine for glutathione production in the liver is provided through this route.

That is why homocysteine is so interesting inside an amino acid profile. It is not a disease of its own. It is a congestion alert for a cycle that is connected to your B vitamin status, your kidney function and your genetics.

Tryptophan and kynurenine: the inflammation window

Most people know tryptophan as the precursor of serotonin. But that is only a narrow side route. By far the larger part is broken down through the kynurenine pathway, and this pathway is ramped up during inflammation by the enzyme indoleamine 2,3-dioxygenase.

That is exactly what makes the ratio of kynurenine to tryptophan an interesting marker. If tryptophan falls while kynurenine rises, that can be a hint towards an activated immune response and not towards too little tryptophan on your plate.

Glutamine and glutamate: fuel and messenger at the same time

Glutamine is the most common free amino acid in blood. It is fuel for gut cells and immune cells, a transport form for nitrogen, and the precursor of glutamate, the most important excitatory messenger in the brain.

This double role makes interpretation difficult. A low glutamine can point to increased consumption in severe illness. But it can also simply be connected to how the sample was processed, because glutamine can break down in unseparated blood. And a ratio of glutamine to glutamate can be calculated, without there being solid intervention studies behind it in the functional field.

Taurine: plenty of research, little clarity for practice

Strictly speaking taurine is not a classical amino acid but an aminosulphonic acid. It arises among other things from cysteine, needs vitamin B6 for that, and is involved in the formation of bile acids, in the regulation of cell volume and in the calcium balance of the heart muscle cell.

In 2023 a large paper in Science drew attention: taurine falls with age, and giving taurine extended lifespan in mice and improved several health parameters in monkeys. In humans the authors found only correlations with age-related diseases, and they wrote explicitly that clinical studies in humans are still needed. That is an important sentence, and it often gets lost when the story is passed on.

Arginine and citrulline: the nitric oxide system

From arginine the inner wall of your vessels produces nitric oxide, the molecule that widens the vessels. Citrulline is both a breakdown product and a precursor, because the body can win arginine back from it.

What is interesting about this axis is less arginine itself than its natural counterpart: asymmetric dimethylarginine, ADMA for short. It arises when methylated proteins are broken down and it can inhibit the enzyme that produces nitric oxide. Reviews describe elevated ADMA levels in connection with disturbed vessel function, inflammation and high blood pressure. In people with rheumatoid arthritis this connection has been studied particularly well.

The framing matters: ADMA is an established research marker. Whether lowering this value changes anything clinically has not been convincingly shown so far. And ADMA is not even included in many standard profiles.

Citrulline in turn is regarded as a marker for the mass of functioning gut cells. Here too a close look is worth it, because even an established marker has limits.

Glycine: the quiet building block of glutathione

Glutathione is the central antioxidant in your cells. It consists of three building blocks: glutamate, cysteine and glycine. Glycine is the most inconspicuous of them and is therefore often overlooked.

A paper from Houston looked at exactly this. In eight older and eight younger people they used stable isotopes to measure how quickly glutathione is actually produced. The older participants had clearly lower glycine and cysteine values in their red blood cells, a lower glutathione concentration and a markedly lower rate of new production. After two weeks with the two precursors, new production rose again.

A later randomised study by the same group in 24 older people over 16 weeks pointed in the same direction and described, alongside glutathione, improvements in inflammatory markers and physical function. These are small studies from a single research group. That belongs to the framing, before anyone makes more of it than it holds.

And now you know why, with a profile, I do not read the lines with the arrows first, but the axes.

Why a high value is often not a deficiency

Now comes the point where intuition misleads most reliably.

Most people read a laboratory sheet like this: value low, so something is missing. Value high, so there is too much. With amino acids that logic often does not hold, because a high value can just as well mean that the body no longer processes something properly.

For me this study is the key to the whole topic. It shows that an amino acid value is a signal from a feedback loop and not a fill level in a tank.

And feedback loops have an uncomfortable property: turning one screw automatically moves others. Amino acids share transport routes into the gut. They compete for the same transporter at the blood-brain barrier. They are broken down by the same enzymes. So anyone who supplies a single amino acid in high doses over months inevitably shifts the pattern of the others.

There is a second thinking error closely connected to this: the assumption that a better laboratory value automatically means a better outcome. With homocysteine this assumption has been tested on a large scale.

And now you know why I prefer to go slowly with this test.

Covering needs, high-dose therapy, and the difference between them

When a profile is on the table, almost always the same question follows: so what do I take now?

At this point a distinction is needed that gets blurred again and again in popular guides, even though it decides benefit and risk.

Covering needs means the low doses you buy online or in the drugstore. They can fill gaps. No therapeutic effect is to be expected from them, and with healthy kidneys and a healthy liver they are, at this order of magnitude and by current knowledge, mostly well tolerated. But no preparation is harmless across the board. That is why even a low dose belongs in the conversation with your doctor.

Orthomolecular or therapeutic high dose means something else: considerably higher amounts, used in a targeted way, limited in time, under medical supervision and with laboratory monitoring. Only here can a nutrient act like a medicine at all. And only here do the risks arise that a medicine brings with it.

The classic example of this difference is vitamin D. For covering needs, the German-speaking professional societies name orders of magnitude from a few hundred to a few thousand international units per day. Which amount fits you depends on your level, your weight and your pre-existing conditions, and it belongs in a medical conversation.

In the so-called Coimbra protocol in multiple sclerosis, by contrast, amounts many times higher are used, under close specialist monitoring of calcium, parathyroid hormone and kidney values and with strict calcium restriction. I deliberately do not name concrete doses here. It is an experimental approach, not an established standard, recommended in no guideline, and without medical supervision it can lead to a dangerous hypercalcaemia. I mention it purely to show the principle: the same substance, two completely different applications.

With amino acids there is an example that sits even closer to the topic. And it turns out to be uncomfortable.

And now you know why I never read a profile as a shopping list.

The four lenses: where amino acid metabolism plays along everywhere at once

In clinical psychoneuroimmunology we look at a symptom through four lenses. Amino acids are a particularly nice example of why that is not a detour but simply biochemistry.

This interweaving explains why an amino acid profile feels so tempting and is so hard to interpret at the same time. It touches all four levels at once. And that is exactly why it cannot say which of them is the decisive one right now.

Costs, self-payers, and the question of when the test is worth it

Now the practical side, because it is often the actual reason for the search.

In Germany, statutory health insurance as a rule only covers an amino acid profile when there is a concrete suspicion of a metabolic disease or a clearly defined clinical situation. Without that reason the test runs as a self-pay service, in practice usually through the German medical fee schedule.

What it costs depends on the scope. A small panel with a few amino acids sits clearly lower than an extensive profile with thirty or more parameters plus additional markers such as homocysteine or kynurenine. Depending on the scope this sits in the double-digit to low three-digit range. A price list helps you less here than a written cost explanation before the draw, which every practice can issue.

The more important question is a different one anyway: what changes, depending on how the result looks? If the honest answer is nothing, then regardless of the price the test is not the best investment.

And now you know why I sometimes advise against a test even though I could offer it.

Three levers you can act on today

No protocol, no brands, no dosages. Just three things that are in your hands.

And now you know why the most honest answer to the question about an amino acid profile starts with a question back: what is supposed to change because of it?

Common questions about the amino acid profile in blood

How this topic connects with the others

An amino acid profile rarely stands alone. If you have the feeling that one finding on its own is not enough, these paths lead further.